Intellectual Property India Publishes Patent Application for Protease Activatable Cytokines And Methods For Making And Using The Same

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202647083583 A) filed by Amunix Pharmaceuticals, Inc. on July 07, 2026, for Protease Activatable Cytokines And Methods For Making And Using The Same.

Inventors include Chauhan, Vibha; Schellenberger, Volker; Johansen, Eric; To, Milton; and Robinson, Aaron.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Provided herein are, inter alia, protease-activatable cytokines, as well as uses and methods of treatment. In particular, protease- activatable IL-12 fusion proteins, where the two subunits p40 and p35 are produced as fusion proteins with at least one masking moiety (Mask) linked to the subunit by a r...